Clinical trial
CEC/EPC and Cardiovascular Risk in Renal Transplant Recipients
NCT00365833 · University of Florida, Other · Terminated
Key facts
| NCT number | NCT00365833 |
|---|---|
| Title | CEC/EPC and Cardiovascular Risk in Renal Transplant Recipients |
| Official title | Circulating Endothelial Cell and Endothelial Progenitor Cell Evaluation of Kidney Transplant Patients |
| Acronym | CEC |
| Lead sponsor | University of Florida, Other |
| Status | Terminated |
| Study type | Observational |
| Conditions | Transplantation, Kidney, Cardiovascular Abnormalities, Cardiovascular Diseases |
| Enrollment | 8 |
| Start date | Jul 1, 2006 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Aug 18, 2006 |
| Last update posted | Sep 30, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: